Botchan A, Hauser R, Gamzu R, Yogev L, Lessing J B, Paz G, Yavetz H
Institute for the Study of Fertility, Serlin Maternity Hospital, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Hum Reprod. 1997 Jan;12(1):73-6. doi: 10.1093/humrep/12.1.73.
The study was conducted to determine the deleterious effect of lymphoma disease on spermatogenesis and to evaluate the possibility that the disease is mediated primarily by inherent mechanisms in Hodgkin's disease and non-Hodgkin's lymphoma patients. A total of 89 patients with lymphoma disease (Hodgkin's and non-Hodgkin's) were referred for sperm preservation prior to adjuvant treatments. A comparison was made of pre- and post-thaw sperm quality between lymphoma patients and healthy volunteers who applied for sperm donation. This was followed by further assessment of the differences between patients with Hodgkin's disease and non-Hodgkin's lymphoma in terms of sperm variables, clinical parameters and blood hormone concentrations. It was found that patients with lymphoma disease had significantly impaired pre-freeze and post-thaw sperm quality compared with that of healthy volunteers. Patients with non-Hodgkin's lymphoma had spermatozoa of higher quality than patients with Hodgkin's disease. No differences were found in the clinical or hormonal parameters between these two groups. As expected, reduced testicular size and abnormal testicular consistency were correlated with decreased sperm quality. The mere presence of cancer disease has a direct negative effect on spermatogenesis, which is probably not related to incidental side-effects. A variable degree of impairment should be expected with different categories of cancer.
本研究旨在确定淋巴瘤疾病对精子发生的有害影响,并评估该疾病主要由霍奇金病和非霍奇金淋巴瘤患者的内在机制介导的可能性。共有89例淋巴瘤疾病(霍奇金病和非霍奇金病)患者在辅助治疗前被转诊进行精子保存。对淋巴瘤患者与申请捐精的健康志愿者解冻前后的精子质量进行了比较。随后,进一步评估了霍奇金病患者和非霍奇金淋巴瘤患者在精子变量、临床参数和血液激素浓度方面的差异。结果发现,与健康志愿者相比,淋巴瘤疾病患者冷冻前和解冻后的精子质量明显受损。非霍奇金淋巴瘤患者的精子质量高于霍奇金病患者。这两组患者的临床或激素参数未发现差异。正如预期的那样,睾丸体积减小和睾丸质地异常与精子质量下降相关。癌症疾病的存在本身对精子发生有直接负面影响,这可能与偶然的副作用无关。不同类型的癌症预计会有不同程度的损害。